Clinical Trial Update: A Study to Compare Sitavig (Acyclovir) Buccal Tablet With a Placebo in the Treatment of Herpes Labialis in Participants Whose Immune System Works Normally [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Sitavig (acyclovir) buccal tablet to placebo for recurrent herpes labialis in immunocompetent participants has completed, with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Labialis

Drugs mentioned

• Sitavig (acyclovir)

Snippet

Sponsor: Bayer | Conditions: Recurrent Herpes Labialis | Phase 3 | Status: COMPLETED | Results posted: 2025-09-02